PetCaseFinder

Peer-reviewed veterinary case report

Glycogen storage disease type IIIa causes collapse in Curly-Coated

By Gregory, Brittany L et al.·Published in Journal of veterinary internal medicine·2007·Department of Microbiology and Molecular Genetics, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Glycogen storage disease type IIIa in curly-coated retrievers.

Species:
dog
Stomach & digestionDogs

Plain-English summary

Two Curly-Coated Retrievers were brought in for symptoms like exercise intolerance, collapsing, and lethargy. Testing revealed they had a genetic condition called glycogen storage disease type IIIa, which is caused by a mutation in a specific gene. This mutation prevents their bodies from properly breaking down glycogen, leading to the buildup of abnormal glycogen in their tissues. A DNA test was developed to identify carriers of this condition, helping to prevent future affected puppies.

People also search for: Curly-Coated Retriever exercise intolerance · dog collapsing after exercise · glycogen storage disease in dogs

Abstract

BACKGROUND: Inborn errors of metabolism impose a significant genetic burden on purebred dogs and cats. The glycogen storage diseases are a category of such disorders that are typed by enzyme analysis, but deoxyribonucleic acid (DNA) based carrier tests are needed for definitive, noninvasive diagnosis and to prevent at-risk matings. HYPOTHESIS: Glycogen storage disease type IIIa (GSD IIIa) is caused by a mutation of the glycogen debranching enzyme gene (AGL) in Curly-Coated Retrievers (CCR). ANIMALS: Two CCR exhibiting episodic exercise intolerance, collapse, and lethargy, and related dogs were studied. METHODS: Structure and amount of glycogen isolated from tissue biopsy specimens was determined by enzymatic digestion, and activities of enzymes of glycogen metabolism were measured. The 33 AGL coding exons and flanking splice sites of an affected dog were amplified by polymerase chain reaction and sequenced. RESULTS: Debranching enzyme activity was undetectable in liver and skeletal muscle of affected dogs, and accumulated glycogen had absent or short outer chains of alpha1, 4-linked glucose. A single adenosine (A) deletion in AGL exon 32 of affected dog genomic DNA predicted a frame-shift and truncation of the protein product by 126 amino acid residues. The mutation was homozygous in affected dogs and heterozygous in both parents. In addition, the deletion mutation was heterozygous in 16 or not detected at all in 31 related but clinically normal CCR. CONCLUSIONS AND CLINICAL IMPORTANCE: GSD IIIa in CCR is an autosomal recessive trait caused by mutation of AGL. A DNA sequence-based carrier test was developed, and carriers were identified in the United States, New Zealand, Australia, and Finland.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17338148/